SCHEMBL12440945

SCHEMBL12440945

Cc1ccc(N2c3ccc(C)cc3Oc3cc(Br)c(Br)cc32)cc1

nearest known ligand 0.36

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
AHR P35869 3/20 0.36
ELANE P08246 2/20 0.35
F2 P00734 1/20 0.35
CTSG P08311 1/20 0.35
CMA1 P23946 1/20 0.35
CTRC Q99895 1/20 0.35
ALDH1A1 P00352 2/20 0.33
HSD17B3 P37058 1/20 0.33
AGTR1 P30556 1/20 0.33
CACNA1B Q00975 1/20 0.33
APBA1 Q02410 1/20 0.33
MGLL Q99685 1/20 0.33
KDM4E B2RXH2 1/20 0.33
GAA P10253 1/20 0.33
CA12 O43570 2/20 0.33
CA1 P00915 2/20 0.33
CA9 Q16790 2/20 0.33
CA2 P00918 1/20 0.33
MAPT P10636 1/20 0.31
MAPK1 P28482 1/20 0.30

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL16327690 0.91 ALDH1A1 (0.36) AHRALDH1A1KDM4EGAAMAPK1
SCHEMBL12374353 0.88 ELANE (0.43) ELANEF2CTSGCMA1CTRC
SCHEMBL12514807 0.86 HSD17B10 (0.41) AHRELANEF2CTSGCMA1
SCHEMBL12440940 0.86 AHR (0.41) AHRELANEF2CTSGCMA1
SCHEMBL28227794 0.85 ALDH1A1 (0.40) AHRELANEF2CTSGCMA1
SCHEMBL13430053 0.83
SCHEMBL13429675 0.83 NPBWR1 (0.33)
SCHEMBL13429571 0.83 FAAH (0.43) ALDH1A1MGLLKDM4ENPC1RAB9A
SCHEMBL13328077 0.82 AHR (0.44) AHRELANEF2CTSGCMA1
SCHEMBL13752329 0.79 P2RX4 (0.44) ELANEF2CTSGCMA1CTRC

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-9318706-B2 Laminated structure, method for producing same, and electronic element comprising same SUMITOMO CHEMICAL COMPANY, LIMITED (JP) 2016-04-19 US disclosed
US-20110177312-A1 LAMINATED STRUCTURE, METHOD FOR PRODUCING SAME, AND ELECTRONIC ELEMENT COMPRISING SAME SUMITOMO CHEMICAL COMPANY, LIMITED (JP) 2011-07-21 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20110177312-A1 LAMINATED STRUCTURE, METHOD FOR PRODUCING SAME, AND ELECTRONIC ELEMENT COMPRISING SAME EPCAM, ITGA1, ITGB1 AHR 660/4885ELANE 942/4885F2 2076/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.